Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,045 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combining efficacy and completion rates with no data imputation: a composite approach with greater sensitivity for the statistical evaluation of active comparisons in antipsychotic trials.
Rabinowitz J, Werbeloff N, Caers I, Mandel FS, Jaeger J, Stauffer V, Menard F, Kinon BJ, Kapur S. Rabinowitz J, et al. Among authors: kapur s. Eur Neuropsychopharmacol. 2014 Mar;24(3):357-68. doi: 10.1016/j.euroneuro.2013.11.010. Epub 2013 Nov 28. Eur Neuropsychopharmacol. 2014. PMID: 24370073 Free article.
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.
Tansey KE, Guipponi M, Perroud N, Bondolfi G, Domenici E, Evans D, Hall SK, Hauser J, Henigsberg N, Hu X, Jerman B, Maier W, Mors O, O'Donovan M, Peters TJ, Placentino A, Rietschel M, Souery D, Aitchison KJ, Craig I, Farmer A, Wendland JR, Malafosse A, Holmans P, Lewis G, Lewis CM, Stensbøl TB, Kapur S, McGuffin P, Uher R. Tansey KE, et al. Among authors: kapur s. PLoS Med. 2012;9(10):e1001326. doi: 10.1371/journal.pmed.1001326. Epub 2012 Oct 16. PLoS Med. 2012. PMID: 23091423 Free PMC article.
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia.
Marder SR, Alphs L, Anghelescu IG, Arango C, Barnes TR, Caers I, Daniel DG, Dunayevich E, Fleischhacker WW, Garibaldi G, Green MF, Harvey PD, Kahn RS, Kane JM, Keefe RS, Kinon B, Leucht S, Lindenmayer JP, Malhotra AK, Stauffer V, Umbricht D, Wesnes K, Kapur S, Rabinowitz J. Marder SR, et al. Among authors: kapur s. Schizophr Res. 2013 Nov;150(2-3):328-33. doi: 10.1016/j.schres.2013.07.058. Epub 2013 Sep 9. Schizophr Res. 2013. PMID: 24028744 Review.
1,045 results